Michael S Silverman
Overview
Explore the profile of Michael S Silverman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
762
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schwartz K, Shuldiner J, Langford B, Brown K, Schultz S, Leung V, et al.
BMJ
. 2024 Jun;
385:e079329.
PMID: 38839101
Objectives: To evaluate whether providing family physicians with feedback on their antibiotic prescribing compared with that of their peers reduces antibiotic prescriptions. To also identify effects on antibiotic prescribing from...
2.
Andary C, Al K, Chmiel J, Gibbons S, Daisley B, Parvathy S, et al.
Trends Mol Med
. 2024 Jan;
30(3):209-222.
PMID: 38195358
Fecal microbiota transplantation (FMT) has emerged as an alternative or adjunct experimental therapy for microbiome-associated diseases following its success in the treatment of recurrent Clostridioides difficile infections (rCDIs). However, the...
3.
Hosseini-Moghaddam S, Kothari S, Humar A, Albasata H, Yetmar Z, Razonable R, et al.
Am J Transplant
. 2023 Nov;
24(4):653-668.
PMID: 37977229
Solid organ transplant recipients (SOTRs) frequently receive adjunctive glucocorticoid therapy (AGT) for Pneumocystis jirovecii pneumonia (PJP). This multicenter cohort of SOTRs with PJP admitted to 20 transplant centers in Canada,...
4.
Routy B, Lenehan J, Miller Jr W, Jamal R, Messaoudene M, Daisley B, et al.
Nat Med
. 2023 Nov;
30(2):604.
PMID: 37923839
No abstract available.
5.
Routy B, Lenehan J, Miller Jr W, Jamal R, Messaoudene M, Daisley B, et al.
Nat Med
. 2023 Jul;
29(8):2121-2132.
PMID: 37414899
Fecal microbiota transplantation (FMT) represents a potential strategy to overcome resistance to immune checkpoint inhibitors in patients with refractory melanoma; however, the role of FMT in first-line treatment settings has...
6.
Shahmirzadi M, Gunaratnam L, Jevnikar A, Luke P, House A, Silverman M, et al.
Transpl Infect Dis
. 2023 May;
25(4):e14081.
PMID: 37247212
Background: Delayed graft function (DGF) increases the renal allograft failure risk. Late-onset Cytomegalovirus (CMV) infection's effect on the association between DGF and allograft failure has not been determined. Methods: In...
7.
Ninkov M, Schmerk C, Moradizadeh M, Parvathy S, Figueredo R, Burton J, et al.
Cancer Immunol Immunother
. 2022 Nov;
72(5):1247-1260.
PMID: 36396738
Strategies to modify the gut microbiome in cancer patients using fecal microbiota transplantation (FMT) have gained momentum as a therapeutic intervention. However, how FMT impacts innate-like, antimicrobial T lymphocytes is...
8.
Tsobo Muanda F, Sood M, Weir M, Sontrop J, Ahmadi F, Yoo E, et al.
JAMA Netw Open
. 2022 Aug;
5(8):e2224892.
PMID: 35917124
Importance: Population-based data are needed to inform the safe prescribing of fluoroquinolone antibiotics to patients with advanced chronic kidney disease (CKD). Objective: To quantify the 14-day risk of a hospital...
9.
Al K, Craven L, Gibbons S, Parvathy S, Wing A, Graf C, et al.
Mult Scler J Exp Transl Clin
. 2022 May;
8(2):20552173221086662.
PMID: 35571974
Background: Patients with MS have an altered gut microbiota compared to healthy individuals, as well as elevated small intestinal permeability, which may be contributing to the development and progression of...
10.
Berkane S, Harizi I, Tayebi A, Silverman M, Stranges S
Int J Public Health
. 2022 Feb;
66:1604312.
PMID: 35140580
With vaccination shortage persisting in many countries, adopting an optimal vaccination program is of crucial importance. Given the slow pace of vaccination campaigns globally, a very relevant and burning public...